Clinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2
Rishi P. Singh, MD
Advertisement
Articles by Rishi P. Singh, MD
Advertisement
Latest Updated Articles
Ultra-widefield imaging contributes to earlier disease detectionPublished: March 20th 2019 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: EU-ROP Registry bridges borders for real-world insight
2
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
3
FLORetina 2025: New horizons in research and risk management for ROP
4
FLORetina 2025: Navigating antithrombotic therapy in wet AMD
5
